The following is a comment received from a reader on the FDA’s request for comments on harmful constitutents, please see this post . How was the request for information approved under the Paperwork Reduction Act? See this CRE post which explains that FDA received an emergency clearance from OMB.
Express your views below in the comments section,; CRE will forward them to FDA and OMB.
Anonymous
June 9th, 2010 at 10:55 am
So far, the FDA/CTP have still not been able to tell us what they will do with the data when they get them.